View in EDS

Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults.

Saved in:
Bibliographic Details
Title: Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults.
Authors: Ali, S.O.1, Yu, X.Q.1, Robbie, G.J.1, Wu, Y.1, Shoemaker, K.1, Yu, L.1, DiGiandomenico, A.1, Keller, A.E.1, Anude, C.2, Hernandez-Illas, M.3, Bellamy, T.1, Falloon, J.1, Dubovsky, F.1, Jafri, H.S.1 JafriH@MedImmune.com
Source: Clinical Microbiology & Infection. May2019, Vol. 25 Issue 5, p629.e1-629.e6. 1p.
Database: Environment Complete
Be the first to leave a comment!
You must be logged in first